Pulmonary Function in Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis
Pediatric Pulmonology · 2026-03 · 61 (3)
DOI: 10.1002/ppul.71580 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pediatric Pulmonology, online erschienen am 22.03.2026. Verfasst von Dafni Moriki und 9 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Pediatrics, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Crohn Disease, Lung, Colitis, Ulcerative. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Background
Pediatric inflammatory bowel disease (IBD) is increasingly recognized as a systemic disorder with potential pulmonary involvement, although abnormalities are often subclinical and underdiagnosed.
Objective
To systematically review and meta‐analyze pulmonary function in children with IBD.
Methods
PubMed and Scopus were searched from inception to June 30, 2025 for observational studies reporting pulmonary function tests in patients younger than 18 years with Crohn's disease (CD) or ulcerative colitis (UC), using relevant keywords. Data were synthesized qualitatively and, where possible, pooled using random‐effects meta‐analysis. Study quality was appraised using the NIH quality assessment tools for observational and case‐control studies.
Results
Eight studies involving 395 children and adolescents (244 with CD, 151 with UC) were included. Spirometry indices were largely preserved: pooled estimated mean difference (MD) for FEV₁% predicted was –2.9 (95% CI: –6.0 to 0.3; p = 0.08) and for FVC% predicted –0.8 (95% CI: –2.1 to 0.5; p = 0.21). FEV₁/FVC ratios showed no significant differences (MD –0.5, 95% CI: –1.6 to 0.5). Lung volumes were comparable (TLC% predicted MD –0.8, 95% CI: –1.9 to 0.3). The most consistent abnormality, although not statistically significant, was reduced diffusing capacity: DLCO% predicted was lower in IBD patients (MD –5.8, 95% CI: –12.4 to 0.9; p = 0.09). FeNO levels were similar (MD 0.2 ppb, 95% CI: –3.4 to 3.8).
Conclusions
Pediatric IBD is associated with predominantly subclinical pulmonary involvement, with reduced diffusing capacity emerging as the most consistent abnormality despite preserved spirometry. Longitudinal studies are needed to clarify the clinical significance and evolution of these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- 3rd Department of Pediatrics, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Nursing, University of West Attica, Athens, Greece.
- Clinical Exercise Physiology and Rehabilitation Laboratory, Physiotherapy Department, School of Health Sciences, University of Thessaly, Lamia, Greece.
- Department of Pediatrics, 1st Pediatric Clinic, Agia Sofia Hospital, Athens, Greece.
ORCID-Profile: Dafni Moriki
Zitieren
APA
Moriki, D., Drosakis, I., Koumpagioti, D., Mavronasou, A., Kalogiannis, M., Tsouprou, M., Kourti, A., Fessatou, S., Kortianou, E., & Douros, K. (2026). Pulmonary Function in Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis. Pediatric Pulmonology, 61(3). https://doi.org/10.1002/ppul.71580
Vancouver
Moriki D, Drosakis I, Koumpagioti D, Mavronasou A, Kalogiannis M, Tsouprou M, et al. Pulmonary Function in Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis. Pediatric Pulmonology. 2026;61(3). doi:10.1002/ppul.71580
BibTeX
@article{Moriki2026,
author = {Moriki, Dafni and Drosakis, Ioannis and Koumpagioti, Despoina and Mavronasou, Aspasia and Kalogiannis, Michalis and Tsouprou, Maria and Kourti, Afroditi and Fessatou, Smaragdi and Kortianou, Eleni and Douros, Konstantinos},
title = {Pulmonary Function in Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {3},
doi = {10.1002/ppul.71580}
}
EUVIMED